Verdict Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Sanofi Q&A: combining drugs and tech to improve diabetes outcomes

Insulin-based drugs alone have struggled to genuinely improve outcomes for diabetes patients. As a result, Sanofi has committed itself to finding new, technological solutions to help patients better self-manage their condition. The company’s global head of integrated care Chris Boulton, who has personal experience with diabetes, explains Sanofi’s long-term history in the condition, as well as how the company’s future approach leverages the technical expertise of partners.

Close
Close
Close

Go Top